Updates on Aflibercept BPCIA Litigation
LexBlog IP
JANUARY 5, 2024
Regeneron seeks a PI schedule to “ensure an orderly process that will result in resolution of its forthcoming motion for PI before May 17, 2024,” when its regulatory exclusivity period ends. Specifically, Regeneron has asserted the following patents. Patent Nos. Patent Nos. Patent Nos.
Let's personalize your content